Erste Group downgraded Novartis (NVS) to Hold from Buy.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Novartis, Radio Therapeutics enter license, collaboration agreement
- Novartis says Pluvicto talks in Canada end without agreement
- Biotech Alert: Searches spiking for these stocks today
- Schrodinger price target raised to $28 from $27 at Goldman Sachs
- Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics